Hem › Neuroendokrina tumörer › Texas
Kliniska studier för Neuroendokrina tumörer i Texas
11 studier för Neuroendokrina tumörer söker deltagare vid platser i Texas.
Städer i Texas
Officiell studietext (engelska)
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Texas Oncology- Baylor Charles A. Sammons Cancer Center, Dallas
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT06943755A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Investigative Site, Houston
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT06881992Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- University of Texas - MD Anderson Cancer Center, Houston
RekryterarFas 1
24 Months – 18 Years · Alla kön · Uppdaterad 25 sep. 2026 · NCT06441331Project: Every Child for Younger Patients With Cancer
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- Medical City Dallas Hospital, Dallas
- och 12 fler
RekryterarObservationsstudie
Upp till ålder 25 · Alla kön · Uppdaterad 25 aug. 2026 · NCT02402244A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
- Crinetics Study Site, Austin
- Crinetics Study Site, Houston
- Crinetics Study Site, Irving
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 31 juli 2026 · NCT07129252A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- UT Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
RekryterarFas 1/2
Ålder 12 och äldre · Alla kön · Uppdaterad 27 maj 2026 · NCT03093116Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors
- Clinical Research Institute at Methodist Health System, Dallas
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 20 mars 2026 · NCT04090034Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- UT Southwestern Medical Center, Dallas
RekryterarFas 4
Ålder 18 till 64 · Alla kön · Uppdaterad 22 jan. 2026 · NCT04373564A Study of MT-4561 in Patients With Various Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 11 dec. 2025 · NCT06943521SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Dallas
- Massive Bio SYNERGY-AI site, Houston
- Massive Bio SYNERGY-AI site, Temple
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
- The University of Texas MD Anderson Cancer Center, Houston
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2025 · NCT06805825Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.